Rooted in science,
proven in market

Find out more

March 24

Orexo R&D Day 2026

A day for investors, analysts and media.

 

 

 

Watch the presentation now

Press releases & news

All press releases

AmorphOX®

Our proprietary drug delivery technology that improves bioavailability and stability for both large and small molecules

Discover AmorphOX

OX640

A revolutionary nasal epinephrine solution for anaphylaxis rescue

Find out more

Partner with us

Together we are stronger. Team up with us for product development and commercialization

Contact details

Our partners

Orexo Insights

Inverview with Robert Rönn, SVP & Head of R&D

Orexo’s AmorphOX® Unlocks New Possibilities for Critical Medicines

Latest report

Report archive

Orexo is committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, environment and anti-corruption. Read more on www.unglobalcompact.org.